Skip to content
Menu
Home
About Us
Chairman’s Profile
Board Of Directors
Team Wockhardt
Corporate Milestones
Research & Development
R&D at Wockhardt
New Drug Discovery
Pipeline / Projects
News & Events
Publications
ZAYNICH
®
WCK 4873
WCK 4282
WCK 6777
Biologicals
News & Events
Pipeline / Projects
Publications
R&D Contact
Our Manufacturing Units
Shendra, India
Biotech Park, India
Daman, India
Ankleshwar, India
Global Footprint
India
UK & Europe
Emerging Markets
Products
India Branded Business
API
Russia – CIS
UK
Irish Market
Emerging Markets
Quality Generics
Quality Policy
Investors
From Chairman’s Office
AGM Speech
Letter to Shareowners
Financials
Annual Report
Quarterly Results
Financial Press Releases
Related Party Transactions
Subsidiary Financials
Annual Return
Corporate Governance
Policies & Codes
Committee’s of the Board
Familiarisation programs
Shareholding Pattern
Secretarial Compliance Report
Authorised KMP
Corporate Actions
Memorandum of Association and Article of Association
ESOP Scheme
Disclosures under Regulation 46 of SEBI LODR Regulations
Announcements / Disclosures
Shareholders Meeting / Postal ballot
AGM Notice
Proceedings
Voting Results
Transcript of the AGM
Postal Ballot Notice
IEPF
Unclaimed Dividend
Nodal Officer
Analyst/ Investors
Presentation
Audio / Video Recording
Transcript
Shareowner Services
FAQ
Green Initiative
Investor Contact
Other Notices
Credit Rating
careers
Introduction
Life@Wockhardt
L&D Initiatives
Voice of Wockhardians
Career@Wockhardt
Media
Press Releases
Wockhardt in Media
ESG
Contact us
Investor Call has concluded
